ClinicalTrials.Veeva

Menu

Mobile Shared Decision-Making Program for ICU Caregivers

C

CHIA-HUI MA

Status

Completed

Conditions

Terminally Ill Patients

Treatments

Other: Placebo Comparator: Placebo
Other: Experimental: Mobile technology devices

Study type

Interventional

Funder types

Other

Identifiers

NCT07469878
21MMHIS127e

Details and patient eligibility

About

By developing a smart mobile shared decision-making (SDM) model, this study aims to assist family members of critically ill end-stage patients in making appropriate decisions, enhance their decision quality, and evaluate the model's effectiveness

Full description

This study utilized a single-blind experimental design and was conducted in the intensive care unit (ICU) of a medical center in northern Taiwan. The study participants were family members responsible for making end-of-life decisions for patients diagnosed with terminally ill critical conditions. Participants were randomly assigned to either the experimental or control group using block randomization software. A total of 70 participants were enrolled, with 35 assigned to the experimental group and 35 to the control group

Enrollment

70 patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

-Patients diagnosed with terminal cancer or the eight designated non-cancer terminal diseases.

Patients determined to have a terminal and irreversible condition by two attending physicians.

Primary family decision-makers who are aged 20 years or older and provide informed consent to participate in the study.

Able to communicate in Mandarin or Taiwanese and possess basic literacy skills.

Exclusion criteria

  • Cases where all family members reside abroad and have appointed an alternative healthcare proxy.

Those who have already received end-of-life decision-making consultations prior to ICU admission.

Patients who already have a Do Not Resuscitate (DNR) status annotated and have confirmed their end-of-life care preferences.

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

70 participants in 2 patient groups, including a placebo group

Mobile technology devices
Experimental group
Description:
mHealth tools 7days
Treatment:
Other: Experimental: Mobile technology devices
Placebo
Placebo Comparator group
Description:
Usual Care
Treatment:
Other: Placebo Comparator: Placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems